Sennosides
- Product NDC
- 69848-016
- 11-digit product format
- 698480016
- Labeler code
- 69848
- Product ID
- 69848-016_468e82c6-8c4a-672c-e063-6394a90a5f0e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Granules USA Inc
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-05-29
- Substance
- SENNOSIDES
- Active strength
- 17.2 mg/17.21
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sennosides
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES | 17.2 mg/17.21 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3FYP5M0IJX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2169295 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a619b8f4-1b5d-181b-e053-2995a90ab729 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| baf7f49c-75b6-496b-a00e-8e766a8e4f03 | Product name | 1 | 20210127 |
| ebc62596-fc97-4d03-9483-7ba095d25db7 | Product name | 1 | 20151210 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69848-016-10 | 2023-03-02 | C162847 | 48780-1 | f386c64a-3279-0266-e053-dadaa90a7c1a | EXTRA STRENGTH Senna Softgels Standerdized Senna Concentrate Sennosides 17.2 mg |
| 69848-016-10 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3279-0266-e053-dadaa90a7c1a | EXTRA STRENGTH Senna Softgels Standerdized Senna Concentrate Sennosides 17.2 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69848-016-10 | Sennosides | 100 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 100 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| up and up fiber therapy | PSYLLIUM HUSK | Target Corporation | 674753ee-1174-4c06-9ed3-a090b338a39e | 2025-11-05 | Warnings | M007 |
| up and up fiber therapy | PSYLLIUM HUSK | TARGET CORPORATION | 956c48f8-c705-4a86-9866-c68a48ddeb6c | 2025-11-05 | Warnings | M007 |
| CEO-TWO | LAXATIVE | Beutlich Pharmaceuticals, LLC | 08670636-5795-4db0-e063-6294a90afa4b | 2025-11-05 | Warnings | M007 |
| up and up gentle laxative | BISACODYL | Target Corporation | 4a29dc2b-b68f-471b-a84e-4a5096aa3748 | 2025-11-04 | Warnings | M007 |
| Target Fiber Laxative | PSYLLIUM HUSK | TARGET CORPORATION | a581116a-392d-4ac3-ae15-4318506a7b2a | 2025-11-04 | Warnings | M007 |
| up and up fiber therapy | CALCIUM POLYCARBOPHIL | Target Corporation. | e5473950-06f4-4ea4-975b-3ac94957e776 | 2025-11-04 | Warnings | M007 |
| up and up fiber therapy Natural Fiber | PSYLLIUM HUSK | Target Corporation | f8b1c831-6fd0-4a58-9726-4e0f986c8084 | 2025-11-04 | Warnings | M007 |
| OneLAX | BISACODYL | AKRON PHARMA INC | be4eeb4d-df29-45dc-94ff-933e52c8b6f6 | 2025-11-03 | Warnings | M007 |
| Gentle Stool Softener | DOCUSATE SODIUM | WALGREEN COMPANY | 169b33f9-e559-47bf-bbba-c7eda4762c7f | 2025-10-31 | Warnings | M007 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Walgreens | 765bfd9b-7a21-4315-9add-cf13007722d5 | 2025-10-31 | Warnings | M007 |
| Gentle Stool Softener | DOCUSATE SODIUM | WALGREEN COMPANY | 71b15339-2585-4fae-8445-6fbb4f0a378e | 2025-10-31 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | Major Pharmaceuticals | 97561cd4-63d9-44c2-a3a3-ec668a09a4ed | 2025-10-31 | Warnings | M007 |
| Fiber Caplets | CALCIUM POLYCARBOPHIL | SAFEWAY | 08e2e8b0-90b3-48d6-a72a-40688c74771a | 2025-10-29 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2025-10-29 | Warnings | M007 |
| Publix Laxative Maximum Strength | CALCIUM SENNOSIDES | PUBLIX SUPER MARKETS, INC | 11112859-ef1e-4b37-9915-ba4d06a3f198 | 2025-10-28 | Warnings | M007 |
| Publix Stimulant Laxative | BISACODYL | PUBLIX SUPER MARKETS, INC | 02e596a7-b8e5-4f55-9bc6-6d17e0fabda7 | 2025-10-28 | Warnings | M007 |
| PUBLIX | PSYLLIUM HUSK | PUBLIX SUPER MARKETS, INC | 55f98d3f-f282-4f19-b373-0b59640d274d | 2025-10-28 | Warnings | M007 |
| PUBLIX | CALCIUM POLYCARBOPHIL | PUBLIX SUPER MARKETS, INC | 02e3f4ce-8961-425c-98a9-3b9d66709ca5 | 2025-10-28 | Warnings | M007 |
| Publix Women Laxative | BISACODYL | PUBLIX SUPER MARKETS, INC | 03eeca55-f239-4a01-a900-c1943f27a834 | 2025-10-28 | Warnings | M007 |
| Publix Fiber Therapy Orange Smooth | PSYLLIUM HUSK | PUBLIX SUPER MARKETS, INC | b9c54c20-cd82-4627-9217-a66834db4799 | 2025-10-28 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2169295 | sennosides 17.2 MG Oral Capsule | PSN | a619b8f4-1b5d-181b-e053-2995a90ab729 | 5 |
| 2169295 | sennosides, USP 17.2 MG Oral Capsule | SCD | a619b8f4-1b5d-181b-e053-2995a90ab729 | 5 |
| 2169295 | sennosides 17.2 MG Oral Capsule | SY | a619b8f4-1b5d-181b-e053-2995a90ab729 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69848-016-10 | 69848001610 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (69848-016-10) | 2020-05-29 | 0000-00-00 | No | No | Current |